Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • mcarnes
    Junior Member
    • Jan 2014
    • 1

    TopHat optimization

    Hi everyone,

    New here. Thanks in advance for any replies to my question.

    I used TopHat to align 50-bp paired-reads sequences from Human samples. My top most expressed transcript was a “novel 50 bp fragment.” This was obviously incorrect and after much digging I found that it went back to a common read that was misaligned.

    The read was incorrectly mapping 14mb away from its mate, but only had 1 mismatch. The correct location (next to its mate) has 3 mismatches. I clearly do not have the optimal parameters selected.

    I originally used:

    tophat -G genes.gtf --mate-inner-dist 250 --mate-std-dev 100 --b2-very-sensitive --no-mixed --library-type fr-unstranded genome read1_R1.fastq read2_R2.fastq

    I would like to give preference to correct mate-pair orientation OVER number of mismatches.

    I am considering changing the following:

    1) Changing --b2-very-sensitive to --b2-sensitive
    2) Removing --no-mixed and/or adding --no-discordant
    3) Increasing --read-mismatches to 3


    Has anyone experienced this issue or have suggestions on how to optimize the parameters?

    Thanks!
  • barkasn
    Junior Member
    • Mar 2012
    • 9

    #2
    The fact that you have a common read that gives you a false positive suggests you have a high duplication rate. Have you QC'd your data?

    I would would start running with default parameters first. It is very easy to spend alot of time optimizing parameters without quite knowing what the effect really is.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 12:17 PM
    0 responses
    13 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    12 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    37 views
    0 reactions
    Last Post SEQadmin2  
    Working...